These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 3784897)
21. Porphyrin-containing polyaspartamide gadolinium complexes as potential magnetic resonance imaging contrast agents. Yan GP; Li Z; Xu W; Zhou CK; Yang L; Zhang Q; Li L; Liu F; Han L; Ge YX; Guo JF Int J Pharm; 2011 Apr; 407(1-2):119-25. PubMed ID: 21272626 [TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system. Oudkerk M; Sijens PE; Van Beek EJ; Kuijpers TJ Invest Radiol; 1995 Feb; 30(2):75-8. PubMed ID: 7782190 [TBL] [Abstract][Full Text] [Related]
23. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
24. NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent. Adzamli K; Periasamy MP; Spiller M; Koenig SH Invest Radiol; 1999 Jun; 34(6):410-4. PubMed ID: 10353033 [TBL] [Abstract][Full Text] [Related]
25. Quantification and excretion kinetics of a magnetic resonance imaging contrast agent by capillary electrophoresis-mass spectrometry. Künnemeyer J; Terborg L; Nowak S; Brauckmann C; Telgmann L; Albert A; Tokmak F; Krämer BK; Günsel A; Wiesmüller GA; Karst U Electrophoresis; 2009 May; 30(10):1766-73. PubMed ID: 19441033 [TBL] [Abstract][Full Text] [Related]
26. Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9. Curtet C; Tellier C; Bohy J; Conti ML; Saccavini JC; Thedrez P; Douillard JY; Chatal JF; Koprowski H Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4277-81. PubMed ID: 3459174 [TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI. Nwe K; Milenic D; Bryant LH; Regino CA; Brechbiel MW J Inorg Biochem; 2011 May; 105(5):722-7. PubMed ID: 21463567 [TBL] [Abstract][Full Text] [Related]
28. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media. Puttagunta NR; Gibby WA; Puttagunta VL Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650 [TBL] [Abstract][Full Text] [Related]
29. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging. Johnston DL; Liu P; Lauffer RB; Newell JB; Wedeen VJ; Rosen BR; Brady TJ; Okada RD J Nucl Med; 1987 May; 28(5):871-7. PubMed ID: 3572546 [TBL] [Abstract][Full Text] [Related]
30. Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything. Koenig SH Acta Radiol Suppl; 1990; 374():17-23. PubMed ID: 1966965 [TBL] [Abstract][Full Text] [Related]
31. In vitro interactions of gadolinium DOTA meglumine and gadolinium DTPA meglumine on hemostasis. Corot C; Belleville J; Paul J; Baguet J; Amiel M; Eloy R Invest Radiol; 1988 Sep; 23 Suppl 1():S261-3. PubMed ID: 3198358 [TBL] [Abstract][Full Text] [Related]
32. Gd-complexes of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-1,4,7,10-tetraacetic acid (DOTA) conjugates of tranexamates as a new class of blood-pool magnetic resonance imaging contrast agents. Gu S; Kim HK; Lee GH; Kang BS; Chang Y; Kim TJ J Med Chem; 2011 Jan; 54(1):143-52. PubMed ID: 21141934 [TBL] [Abstract][Full Text] [Related]
33. Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent. Runge VM; Kaufman DM; Wood ML; Adelman LS; Jacobson S Int J Rad Appl Instrum B; 1989; 16(6):561-7. PubMed ID: 2606711 [TBL] [Abstract][Full Text] [Related]
34. 1H-NMR relaxation times and water compartmentalization in experimental tumor models. Braunschweiger PG; Schiffer LM; Furmanski P Magn Reson Imaging; 1986; 4(4):335-42. PubMed ID: 3669948 [TBL] [Abstract][Full Text] [Related]
35. Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry. Vander Elst L; Van Haverbeke Y; Goudemant JF; Muller RN Magn Reson Med; 1994 Apr; 31(4):437-44. PubMed ID: 8208120 [TBL] [Abstract][Full Text] [Related]
36. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics. Shiraishi K; Kawano K; Maitani Y; Yokoyama M J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796 [TBL] [Abstract][Full Text] [Related]
37. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties. Allard M; Doucet D; Kien P; Bonnemain B; Caillé JM Invest Radiol; 1988 Sep; 23 Suppl 1():S271-4. PubMed ID: 3198361 [TBL] [Abstract][Full Text] [Related]
38. Pseudolayering of Gd-DTPA in the urinary bladder. Elster AD; Sobol WT; Hinson WH Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649 [TBL] [Abstract][Full Text] [Related]
39. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents. Ratzinger G; Agrawal P; Körner W; Lonkai J; Sanders HM; Terreno E; Wirth M; Strijkers GJ; Nicolay K; Gabor F Biomaterials; 2010 Nov; 31(33):8716-23. PubMed ID: 20797782 [TBL] [Abstract][Full Text] [Related]
40. New gadolinium complexes as magnetic resonance imaging--contrast agents. Wagner M; Ruloff R; Hoyer E; Gründer W Z Naturforsch C J Biosci; 1997; 52(7-8):508-15. PubMed ID: 9376038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]